Diamond Equity Research Releases Update Note on Imugene Limited (ASX: IMU)

New York, May 20, 2026 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an update note on Imugene Ltd. (ASX: IMU) resuming coverage. The research summary below is from a report commissioned by Imugene Ltd. and produced by Diamond Equity Research. The in-depth 24-page update note includes detailed information on the Imugene's business model, industry, financial results, and risks.